ELMD vs OGN · P/E 33, rev $73.8M vs P/E 3.4, rev $3.02B
Electromed Inc (ELMD) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Electromed Inc (ELMD) is a medical devices company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ELMD revenue for 2026-06-30 was $73.8M. Net income was $11.3M. Revenue was up 15.3% from 2025-06-30 to 2026-06-30. ELMD currently screens at market cap $316.8M and trailing P/E 32.7.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ELMD currently screens at market cap $316.8M and trailing P/E 32.7. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ELMD and OGN stock pages for the full models.
Not investment advice.